Cargando…
Hepatic Sinusoidal Obstruction Syndrome in a Patient With Multiple Myeloma Treated With CyBorD
Hepatic sinusoidal obstruction syndrome (SOS) is a life-threatening state generally occurring as a complication of conditioning regimens used for hematopoietic stem cell transplant. Hepatic SOS after a standard dose of chemotherapy in malignancies is rare, and there are only a few cases in pediatric...
Autores principales: | Tariq, Tooba, Dawdy, John, Goyal, Sachin, Mohamad, Bashar, Singh, Manmeet, Mutchnick, Milton, Ehrinpreis, Murray |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722380/ https://www.ncbi.nlm.nih.gov/pubmed/31620512 http://dx.doi.org/10.14309/crj.0000000000000103 |
Ejemplares similares
-
Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis
por: Theodorakakou, Foteini, et al.
Publicado: (2021) -
Hepatic AL Amyloidosis without Significant Light Chain Elevation in a Patient Treated with CyBorD Plus Daratumumab
por: Rybinski, Brad, et al.
Publicado: (2021) -
Cyclophosphamide, bortezomib and dexamethasone (CyBorD) induction for newly diagnosed multiple myeloma: High response rates in a phase II clinical trial
por: Reeder, Craig B., et al.
Publicado: (2009) -
A patient with POEMS syndrome responding to modified CyBorD chemotherapy as a bridge to autologous stem cell transplantation
por: Milam, Emily C., et al.
Publicado: (2019) -
Racial Disparity in HCV Demographics and Treatment Between Interferon Era (2002–2003) and Direct Acting Anti-viral Era (2019)
por: Naylor, Paul, et al.
Publicado: (2023)